If You Invested in Yijia Group Corp (YJGJ)

Yijia Group Corp. (trading under the symbol YJGJ) is a Nevada corporation whose common stock is quoted on the OTC Pink Sheets. According to its filings with the U.S. Securities and Exchange Commission (SEC), the company has undertaken several corporate actions involving its capital structure and corporate identity. These actions are documented in its current reports on Form 8-K and related amendments to its Articles of Incorporation filed with the Secretary of State of the State of Nevada.

The company has disclosed that its principal office is located in New York, New York, and that it is incorporated in the State of Nevada under Commission File Number 333-218733 and Employer Identification Number 35-2583762. Its common stock has a par value of $0.001 per share, and the company has also authorized preferred stock, as described in its certificates of amendment and designation.

Corporate name change to VitaNova Life Sciences Corporation

In a Form 8-K, Yijia Group Corp. reported that its Board of Directors and a majority of the holders of its issued and outstanding common stock approved a name change from Yijia Group Corp. to VitaNova Life Sciences Corporation. The company states that a Certificate of Amendment to its Articles of Incorporation effecting this name change was filed with the Secretary of State of the State of Nevada and became effective on January 9, 2026. As of the date of that Form 8-K, the Financial Industry Regulatory Authority (FINRA) was processing the name change.

This means that, from a corporate law perspective in Nevada, the entity historically known as Yijia Group Corp. has changed its corporate name to VitaNova Life Sciences Corporation. The company has also indicated its intention to change its ticker symbol in connection with this name change and is evaluating potential new symbols, although YJGJ remains the trading symbol referenced in the filings as of the dates of those reports.

Reverse stock split and capital structure changes

Yijia Group Corp. has reported that its Board of Directors and a majority of the holders of its issued and outstanding common stock approved a reverse stock split of its common stock. The company initially disclosed that it proposed a reverse split in a range of 1-for-2 to 1-for-3, and later reported that the Board approved the reverse split to be effectuated at a ratio of 1-for-3. Under this reverse split, each holder of common stock is to receive one share of common stock for every three shares held.

The company states that the Certificate of Amendment filed on January 9, 2026 also effectuates this reverse split. As with the name change, the company reports that FINRA is processing the reverse split as of the date of the relevant Form 8-K.

Yijia Group Corp. has also described several changes to its authorized share capital. In a prior Certificate of Amendment that became effective on November 12, 2025, the company increased the total number of authorized shares of capital stock to 210,000,000, consisting of 200,000,000 shares of common stock and 10,000,000 shares of initially undesignated preferred stock, each with a par value of $0.001 per share. The company notes that this change of share capital, including the authorization of blank check preferred stock, was approved by the Board and a majority of the holders of its issued and outstanding common stock through written consent.

The company further reports that it filed a Certificate of Correction on November 21, 2025 to correct a scrivener’s error in the earlier Certificate of Amendment relating to the par value of the common stock.

Preferred stock designation

In addition to authorizing preferred stock, Yijia Group Corp. filed a Certificate of Designation on November 21, 2025, designating 3,000,000 shares of its authorized preferred stock as Series A Preferred Stock. The Certificate of Designation sets forth the powers, preferences, rights, qualifications, limitations and restrictions of the Series A Preferred Stock. The company states that this designation was approved by the Board and a majority of the holders of its issued and outstanding common stock through written consent.

These steps indicate that the company has created a class of preferred equity with specific terms, although the detailed rights and preferences are contained in the Certificate of Designation referenced as an exhibit to the Form 8-K.

CUSIP and ticker symbol considerations

In connection with the name change and reverse stock split, Yijia Group Corp. reports that it has applied for and obtained a new CUSIP number for its common stock, identified in the Form 8-K as 98585W403. The company also states that it intends to change its ticker symbol and, as of the date of the Form 8-K, is evaluating potential new ticker symbols. Until any new symbol becomes effective, the filings indicate that the company’s common stock continues to be associated with the symbol YJGJ on the OTC Pink Sheets.

Regulatory reporting and status

Yijia Group Corp. files current reports on Form 8-K with the SEC to disclose material corporate events such as amendments to its Articles of Incorporation, changes to its capital structure, and other significant corporate actions. The filings also indicate that the company is not identified as an emerging growth company under the definitions used in SEC rules, based on the check box disclosures in the forms.

While the company’s industry and operating business are not described in the available filings summarized here, the documents provide detail on its corporate governance decisions, capital structure, and the transition of its corporate name to VitaNova Life Sciences Corporation.

Key structural features from filings

• Nevada corporation with principal office in New York, New York, as stated in its Form 8-K filings.
• Common stock trading on OTC Pink Sheets under the symbol YJGJ, as disclosed in the securities registration table in the Form 8-K.
• Corporate name change approved and effected in Nevada from Yijia Group Corp. to VitaNova Life Sciences Corporation.
• Reverse stock split at a 1-for-3 ratio, implemented through a Certificate of Amendment.
• Increase in authorized capital stock to 210,000,000 shares, including common and preferred stock, and authorization of blank check preferred stock.
• Designation of 3,000,000 shares of Series A Preferred Stock with specific powers and preferences set forth in a Certificate of Designation.
• New CUSIP number obtained for the common stock in connection with the name change and reverse split.